Timpani Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Timpani Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-130,014	Closed	-$4.29M	–	119
2017 Q3	$4.29M	Sell	130,014 -27,946	-18%	-$968K	1.57%	19
2017 Q2	$5.28M	Buy	157,960 +67,626	+75%	+$2.02M	1.96%	5
2017 Q1	$2.62M	Sell	90,334 -4,878	-5%	-$121K	1.05%	44
2016 Q4	$2.13M	Buy	95,212 +24,041	+34%	+$470K	0.89%	48
2016 Q3	$1.32M	Sell	71,171 -11	-0%	-$207	0.53%	67
2016 Q2	$1.16M	Sell	71,182 -43,946	-38%	-$646K	0.49%	74
2016 Q1	$1.34M	Sell	115,128 -100,673	-47%	-$1.12M	0.57%	70
2015 Q4	$2.52M	Sell	215,801 -12,243	-5%	-$155K	1.02%	42
2015 Q3	$2.79M	Buy	+228,044	New	+$2.91M	1.13%	35

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Timpani Capital Management's BEAT Position: Q4 2017 in Review

Timpani Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2017, closing a stake of 130,014 shares — an estimated $4.29M sold.

Timpani Capital Management first reported a position in BEAT in Q3 2015 and held it in 9 quarters. The position peaked at $5.28M in Q2 2017. 192 funds tracked by Wall St. Rank hold BEAT as of Q4 2017.

Timpani Capital Management reported no remaining BioTelemetry, Inc. position as of Q4 2017 after selling out during the quarter.
Timpani Capital Management sold 130,014 BioTelemetry, Inc. shares in Q4 2017, an estimated $4.29M.
Timpani Capital Management first reported a position in BioTelemetry, Inc. in Q3 2015 and held it in 9 quarters.
Timpani Capital Management's BioTelemetry, Inc. position peaked at $5.28M in Q2 2017.
192 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2017.

Based on Timpani Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.